nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—CYP3A7—Sorafenib—liver cancer	0.144	0.253	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.144	0.253	CbGbCtD
Oxycodone—CYP3A5—Sorafenib—liver cancer	0.108	0.189	CbGbCtD
Oxycodone—CYP2D6—Sorafenib—liver cancer	0.0661	0.116	CbGbCtD
Oxycodone—CYP3A4—Sorafenib—liver cancer	0.042	0.0739	CbGbCtD
Oxycodone—CYP2D6—Doxorubicin—liver cancer	0.0401	0.0705	CbGbCtD
Oxycodone—CYP3A4—Doxorubicin—liver cancer	0.0255	0.0448	CbGbCtD
Oxycodone—Hypoglycaemia—Epirubicin—liver cancer	0.000629	0.00171	CcSEcCtD
Oxycodone—Cardiac failure—Epirubicin—liver cancer	0.000629	0.00171	CcSEcCtD
Oxycodone—Hyponatraemia—Epirubicin—liver cancer	0.000616	0.00168	CcSEcCtD
Oxycodone—Increased appetite—Doxorubicin—liver cancer	0.000605	0.00165	CcSEcCtD
Oxycodone—Affect lability—Epirubicin—liver cancer	0.000604	0.00164	CcSEcCtD
Oxycodone—Migraine—Epirubicin—liver cancer	0.000604	0.00164	CcSEcCtD
Oxycodone—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000602	0.00164	CcSEcCtD
Oxycodone—Hypersensitivity—Sorafenib—liver cancer	0.000601	0.00164	CcSEcCtD
Oxycodone—Dermatitis bullous—Doxorubicin—liver cancer	0.000594	0.00162	CcSEcCtD
Oxycodone—Face oedema—Epirubicin—liver cancer	0.000593	0.00161	CcSEcCtD
Oxycodone—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000587	0.0016	CcSEcCtD
Oxycodone—Asthenia—Sorafenib—liver cancer	0.000586	0.00159	CcSEcCtD
Oxycodone—Cardiac arrest—Epirubicin—liver cancer	0.000584	0.00159	CcSEcCtD
Oxycodone—Hypoglycaemia—Doxorubicin—liver cancer	0.000582	0.00158	CcSEcCtD
Oxycodone—Cardiac failure—Doxorubicin—liver cancer	0.000582	0.00158	CcSEcCtD
Oxycodone—Mood swings—Epirubicin—liver cancer	0.000581	0.00158	CcSEcCtD
Oxycodone—Pruritus—Sorafenib—liver cancer	0.000578	0.00157	CcSEcCtD
Oxycodone—Dehydration—Epirubicin—liver cancer	0.000571	0.00155	CcSEcCtD
Oxycodone—Hyponatraemia—Doxorubicin—liver cancer	0.00057	0.00155	CcSEcCtD
Oxycodone—Dry skin—Epirubicin—liver cancer	0.000563	0.00153	CcSEcCtD
Oxycodone—Abdominal pain upper—Epirubicin—liver cancer	0.000561	0.00153	CcSEcCtD
Oxycodone—Orthostatic hypotension—Epirubicin—liver cancer	0.000561	0.00153	CcSEcCtD
Oxycodone—Affect lability—Doxorubicin—liver cancer	0.000559	0.00152	CcSEcCtD
Oxycodone—Migraine—Doxorubicin—liver cancer	0.000559	0.00152	CcSEcCtD
Oxycodone—Diarrhoea—Sorafenib—liver cancer	0.000559	0.00152	CcSEcCtD
Oxycodone—Breast disorder—Epirubicin—liver cancer	0.000555	0.00151	CcSEcCtD
Oxycodone—Nasopharyngitis—Epirubicin—liver cancer	0.000549	0.00149	CcSEcCtD
Oxycodone—Face oedema—Doxorubicin—liver cancer	0.000548	0.00149	CcSEcCtD
Oxycodone—Gastritis—Epirubicin—liver cancer	0.000543	0.00148	CcSEcCtD
Oxycodone—Cardiac arrest—Doxorubicin—liver cancer	0.00054	0.00147	CcSEcCtD
Oxycodone—Dizziness—Sorafenib—liver cancer	0.00054	0.00147	CcSEcCtD
Oxycodone—Mood swings—Doxorubicin—liver cancer	0.000538	0.00146	CcSEcCtD
Oxycodone—Abdominal distension—Epirubicin—liver cancer	0.000534	0.00145	CcSEcCtD
Oxycodone—Influenza—Epirubicin—liver cancer	0.000531	0.00144	CcSEcCtD
Oxycodone—Asthma—Epirubicin—liver cancer	0.000531	0.00144	CcSEcCtD
Oxycodone—Dysphagia—Epirubicin—liver cancer	0.000531	0.00144	CcSEcCtD
Oxycodone—Dehydration—Doxorubicin—liver cancer	0.000528	0.00144	CcSEcCtD
Oxycodone—Dry skin—Doxorubicin—liver cancer	0.000521	0.00142	CcSEcCtD
Oxycodone—Vomiting—Sorafenib—liver cancer	0.000519	0.00141	CcSEcCtD
Oxycodone—Abdominal pain upper—Doxorubicin—liver cancer	0.000519	0.00141	CcSEcCtD
Oxycodone—Orthostatic hypotension—Doxorubicin—liver cancer	0.000519	0.00141	CcSEcCtD
Oxycodone—Rash—Sorafenib—liver cancer	0.000515	0.0014	CcSEcCtD
Oxycodone—Dermatitis—Sorafenib—liver cancer	0.000514	0.0014	CcSEcCtD
Oxycodone—Breast disorder—Doxorubicin—liver cancer	0.000513	0.0014	CcSEcCtD
Oxycodone—Headache—Sorafenib—liver cancer	0.000511	0.00139	CcSEcCtD
Oxycodone—Bronchitis—Epirubicin—liver cancer	0.00051	0.00139	CcSEcCtD
Oxycodone—Nasopharyngitis—Doxorubicin—liver cancer	0.000508	0.00138	CcSEcCtD
Oxycodone—Gastritis—Doxorubicin—liver cancer	0.000503	0.00137	CcSEcCtD
Oxycodone—Dysuria—Epirubicin—liver cancer	0.000496	0.00135	CcSEcCtD
Oxycodone—Abdominal distension—Doxorubicin—liver cancer	0.000494	0.00135	CcSEcCtD
Oxycodone—Dysphagia—Doxorubicin—liver cancer	0.000491	0.00134	CcSEcCtD
Oxycodone—Influenza—Doxorubicin—liver cancer	0.000491	0.00134	CcSEcCtD
Oxycodone—Asthma—Doxorubicin—liver cancer	0.000491	0.00134	CcSEcCtD
Oxycodone—Nausea—Sorafenib—liver cancer	0.000485	0.00132	CcSEcCtD
Oxycodone—Photosensitivity reaction—Epirubicin—liver cancer	0.000484	0.00132	CcSEcCtD
Oxycodone—Weight decreased—Epirubicin—liver cancer	0.00048	0.00131	CcSEcCtD
Oxycodone—Hyperglycaemia—Epirubicin—liver cancer	0.000479	0.0013	CcSEcCtD
Oxycodone—Pneumonia—Epirubicin—liver cancer	0.000476	0.0013	CcSEcCtD
Oxycodone—Infestation NOS—Epirubicin—liver cancer	0.000473	0.00129	CcSEcCtD
Oxycodone—Infestation—Epirubicin—liver cancer	0.000473	0.00129	CcSEcCtD
Oxycodone—Drowsiness—Epirubicin—liver cancer	0.000473	0.00129	CcSEcCtD
Oxycodone—Bronchitis—Doxorubicin—liver cancer	0.000472	0.00129	CcSEcCtD
Oxycodone—Stomatitis—Epirubicin—liver cancer	0.000461	0.00126	CcSEcCtD
Oxycodone—Urinary tract infection—Epirubicin—liver cancer	0.00046	0.00125	CcSEcCtD
Oxycodone—Dysuria—Doxorubicin—liver cancer	0.000459	0.00125	CcSEcCtD
Oxycodone—Sweating—Epirubicin—liver cancer	0.000453	0.00123	CcSEcCtD
Oxycodone—Haematuria—Epirubicin—liver cancer	0.000451	0.00123	CcSEcCtD
Oxycodone—Photosensitivity reaction—Doxorubicin—liver cancer	0.000448	0.00122	CcSEcCtD
Oxycodone—Hepatobiliary disease—Epirubicin—liver cancer	0.000447	0.00122	CcSEcCtD
Oxycodone—Epistaxis—Epirubicin—liver cancer	0.000446	0.00121	CcSEcCtD
Oxycodone—Weight decreased—Doxorubicin—liver cancer	0.000444	0.00121	CcSEcCtD
Oxycodone—Sinusitis—Epirubicin—liver cancer	0.000444	0.00121	CcSEcCtD
Oxycodone—Hyperglycaemia—Doxorubicin—liver cancer	0.000443	0.00121	CcSEcCtD
Oxycodone—Pneumonia—Doxorubicin—liver cancer	0.00044	0.0012	CcSEcCtD
Oxycodone—Infestation NOS—Doxorubicin—liver cancer	0.000438	0.00119	CcSEcCtD
Oxycodone—Infestation—Doxorubicin—liver cancer	0.000438	0.00119	CcSEcCtD
Oxycodone—Drowsiness—Doxorubicin—liver cancer	0.000438	0.00119	CcSEcCtD
Oxycodone—Bradycardia—Epirubicin—liver cancer	0.000432	0.00118	CcSEcCtD
Oxycodone—Haemoglobin—Epirubicin—liver cancer	0.000427	0.00116	CcSEcCtD
Oxycodone—Stomatitis—Doxorubicin—liver cancer	0.000427	0.00116	CcSEcCtD
Oxycodone—Rhinitis—Epirubicin—liver cancer	0.000426	0.00116	CcSEcCtD
Oxycodone—Urinary tract infection—Doxorubicin—liver cancer	0.000425	0.00116	CcSEcCtD
Oxycodone—Haemorrhage—Epirubicin—liver cancer	0.000425	0.00116	CcSEcCtD
Oxycodone—Hepatitis—Epirubicin—liver cancer	0.000425	0.00116	CcSEcCtD
Oxycodone—Hypoaesthesia—Epirubicin—liver cancer	0.000423	0.00115	CcSEcCtD
Oxycodone—Pharyngitis—Epirubicin—liver cancer	0.000421	0.00115	CcSEcCtD
Oxycodone—Sweating—Doxorubicin—liver cancer	0.00042	0.00114	CcSEcCtD
Oxycodone—Urinary tract disorder—Epirubicin—liver cancer	0.000419	0.00114	CcSEcCtD
Oxycodone—Oedema peripheral—Epirubicin—liver cancer	0.000418	0.00114	CcSEcCtD
Oxycodone—Haematuria—Doxorubicin—liver cancer	0.000417	0.00114	CcSEcCtD
Oxycodone—Connective tissue disorder—Epirubicin—liver cancer	0.000417	0.00114	CcSEcCtD
Oxycodone—Urethral disorder—Epirubicin—liver cancer	0.000416	0.00113	CcSEcCtD
Oxycodone—Hepatobiliary disease—Doxorubicin—liver cancer	0.000414	0.00113	CcSEcCtD
Oxycodone—Epistaxis—Doxorubicin—liver cancer	0.000413	0.00112	CcSEcCtD
Oxycodone—Sinusitis—Doxorubicin—liver cancer	0.000411	0.00112	CcSEcCtD
Oxycodone—Visual impairment—Epirubicin—liver cancer	0.000409	0.00111	CcSEcCtD
Oxycodone—Bradycardia—Doxorubicin—liver cancer	0.0004	0.00109	CcSEcCtD
Oxycodone—Eye disorder—Epirubicin—liver cancer	0.000397	0.00108	CcSEcCtD
Oxycodone—Tinnitus—Epirubicin—liver cancer	0.000396	0.00108	CcSEcCtD
Oxycodone—Haemoglobin—Doxorubicin—liver cancer	0.000395	0.00108	CcSEcCtD
Oxycodone—Cardiac disorder—Epirubicin—liver cancer	0.000394	0.00107	CcSEcCtD
Oxycodone—Flushing—Epirubicin—liver cancer	0.000394	0.00107	CcSEcCtD
Oxycodone—Rhinitis—Doxorubicin—liver cancer	0.000394	0.00107	CcSEcCtD
Oxycodone—Hepatitis—Doxorubicin—liver cancer	0.000393	0.00107	CcSEcCtD
Oxycodone—Haemorrhage—Doxorubicin—liver cancer	0.000393	0.00107	CcSEcCtD
Oxycodone—Hypoaesthesia—Doxorubicin—liver cancer	0.000391	0.00106	CcSEcCtD
Oxycodone—Pharyngitis—Doxorubicin—liver cancer	0.00039	0.00106	CcSEcCtD
Oxycodone—Urinary tract disorder—Doxorubicin—liver cancer	0.000388	0.00106	CcSEcCtD
Oxycodone—Oedema peripheral—Doxorubicin—liver cancer	0.000387	0.00105	CcSEcCtD
Oxycodone—Connective tissue disorder—Doxorubicin—liver cancer	0.000386	0.00105	CcSEcCtD
Oxycodone—Angiopathy—Epirubicin—liver cancer	0.000385	0.00105	CcSEcCtD
Oxycodone—Urethral disorder—Doxorubicin—liver cancer	0.000385	0.00105	CcSEcCtD
Oxycodone—Immune system disorder—Epirubicin—liver cancer	0.000384	0.00104	CcSEcCtD
Oxycodone—Mediastinal disorder—Epirubicin—liver cancer	0.000383	0.00104	CcSEcCtD
Oxycodone—Chills—Epirubicin—liver cancer	0.000381	0.00104	CcSEcCtD
Oxycodone—Visual impairment—Doxorubicin—liver cancer	0.000379	0.00103	CcSEcCtD
Oxycodone—Mental disorder—Epirubicin—liver cancer	0.000372	0.00101	CcSEcCtD
Oxycodone—Malnutrition—Epirubicin—liver cancer	0.00037	0.00101	CcSEcCtD
Oxycodone—Eye disorder—Doxorubicin—liver cancer	0.000367	0.001	CcSEcCtD
Oxycodone—Tinnitus—Doxorubicin—liver cancer	0.000366	0.000997	CcSEcCtD
Oxycodone—Flushing—Doxorubicin—liver cancer	0.000365	0.000993	CcSEcCtD
Oxycodone—Cardiac disorder—Doxorubicin—liver cancer	0.000365	0.000993	CcSEcCtD
Oxycodone—Flatulence—Epirubicin—liver cancer	0.000364	0.000992	CcSEcCtD
Oxycodone—Tension—Epirubicin—liver cancer	0.000363	0.000988	CcSEcCtD
Oxycodone—Dysgeusia—Epirubicin—liver cancer	0.000362	0.000986	CcSEcCtD
Oxycodone—Nervousness—Epirubicin—liver cancer	0.000359	0.000977	CcSEcCtD
Oxycodone—Back pain—Epirubicin—liver cancer	0.000358	0.000973	CcSEcCtD
Oxycodone—Angiopathy—Doxorubicin—liver cancer	0.000356	0.00097	CcSEcCtD
Oxycodone—Muscle spasms—Epirubicin—liver cancer	0.000355	0.000968	CcSEcCtD
Oxycodone—Immune system disorder—Doxorubicin—liver cancer	0.000355	0.000966	CcSEcCtD
Oxycodone—Mediastinal disorder—Doxorubicin—liver cancer	0.000354	0.000964	CcSEcCtD
Oxycodone—Chills—Doxorubicin—liver cancer	0.000353	0.00096	CcSEcCtD
Oxycodone—Mental disorder—Doxorubicin—liver cancer	0.000344	0.000937	CcSEcCtD
Oxycodone—Ill-defined disorder—Epirubicin—liver cancer	0.000343	0.000934	CcSEcCtD
Oxycodone—Malnutrition—Doxorubicin—liver cancer	0.000342	0.000931	CcSEcCtD
Oxycodone—Anaemia—Epirubicin—liver cancer	0.000342	0.00093	CcSEcCtD
Oxycodone—Agitation—Epirubicin—liver cancer	0.00034	0.000925	CcSEcCtD
Oxycodone—Flatulence—Doxorubicin—liver cancer	0.000337	0.000918	CcSEcCtD
Oxycodone—Tension—Doxorubicin—liver cancer	0.000336	0.000914	CcSEcCtD
Oxycodone—Dysgeusia—Doxorubicin—liver cancer	0.000335	0.000912	CcSEcCtD
Oxycodone—Malaise—Epirubicin—liver cancer	0.000333	0.000908	CcSEcCtD
Oxycodone—Nervousness—Doxorubicin—liver cancer	0.000332	0.000904	CcSEcCtD
Oxycodone—Vertigo—Epirubicin—liver cancer	0.000332	0.000904	CcSEcCtD
Oxycodone—Syncope—Epirubicin—liver cancer	0.000331	0.000902	CcSEcCtD
Oxycodone—Leukopenia—Epirubicin—liver cancer	0.000331	0.000901	CcSEcCtD
Oxycodone—Back pain—Doxorubicin—liver cancer	0.000331	0.000901	CcSEcCtD
Oxycodone—Muscle spasms—Doxorubicin—liver cancer	0.000329	0.000895	CcSEcCtD
Oxycodone—Palpitations—Epirubicin—liver cancer	0.000327	0.000889	CcSEcCtD
Oxycodone—Loss of consciousness—Epirubicin—liver cancer	0.000325	0.000885	CcSEcCtD
Oxycodone—Cough—Epirubicin—liver cancer	0.000323	0.000878	CcSEcCtD
Oxycodone—Naloxone—ESR1—liver cancer	0.000321	0.692	CrCbGaD
Oxycodone—Convulsion—Epirubicin—liver cancer	0.00032	0.000872	CcSEcCtD
Oxycodone—Ill-defined disorder—Doxorubicin—liver cancer	0.000317	0.000864	CcSEcCtD
Oxycodone—Anaemia—Doxorubicin—liver cancer	0.000316	0.000861	CcSEcCtD
Oxycodone—Chest pain—Epirubicin—liver cancer	0.000315	0.000857	CcSEcCtD
Oxycodone—Myalgia—Epirubicin—liver cancer	0.000315	0.000857	CcSEcCtD
Oxycodone—Arthralgia—Epirubicin—liver cancer	0.000315	0.000857	CcSEcCtD
Oxycodone—Agitation—Doxorubicin—liver cancer	0.000314	0.000856	CcSEcCtD
Oxycodone—Anxiety—Epirubicin—liver cancer	0.000314	0.000854	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000313	0.000851	CcSEcCtD
Oxycodone—Discomfort—Epirubicin—liver cancer	0.000311	0.000847	CcSEcCtD
Oxycodone—Malaise—Doxorubicin—liver cancer	0.000308	0.00084	CcSEcCtD
Oxycodone—Dry mouth—Epirubicin—liver cancer	0.000308	0.000838	CcSEcCtD
Oxycodone—Vertigo—Doxorubicin—liver cancer	0.000307	0.000837	CcSEcCtD
Oxycodone—Syncope—Doxorubicin—liver cancer	0.000307	0.000835	CcSEcCtD
Oxycodone—Leukopenia—Doxorubicin—liver cancer	0.000306	0.000834	CcSEcCtD
Oxycodone—Confusional state—Epirubicin—liver cancer	0.000304	0.000828	CcSEcCtD
Oxycodone—Palpitations—Doxorubicin—liver cancer	0.000302	0.000823	CcSEcCtD
Oxycodone—Oedema—Epirubicin—liver cancer	0.000302	0.000821	CcSEcCtD
Oxycodone—Anaphylactic shock—Epirubicin—liver cancer	0.000302	0.000821	CcSEcCtD
Oxycodone—Loss of consciousness—Doxorubicin—liver cancer	0.000301	0.000818	CcSEcCtD
Oxycodone—Infection—Epirubicin—liver cancer	0.0003	0.000816	CcSEcCtD
Oxycodone—Cough—Doxorubicin—liver cancer	0.000298	0.000813	CcSEcCtD
Oxycodone—Shock—Epirubicin—liver cancer	0.000297	0.000808	CcSEcCtD
Oxycodone—Convulsion—Doxorubicin—liver cancer	0.000296	0.000807	CcSEcCtD
Oxycodone—Nervous system disorder—Epirubicin—liver cancer	0.000296	0.000805	CcSEcCtD
Oxycodone—Tachycardia—Epirubicin—liver cancer	0.000294	0.000802	CcSEcCtD
Oxycodone—Skin disorder—Epirubicin—liver cancer	0.000293	0.000798	CcSEcCtD
Oxycodone—Hyperhidrosis—Epirubicin—liver cancer	0.000292	0.000794	CcSEcCtD
Oxycodone—Arthralgia—Doxorubicin—liver cancer	0.000291	0.000793	CcSEcCtD
Oxycodone—Myalgia—Doxorubicin—liver cancer	0.000291	0.000793	CcSEcCtD
Oxycodone—Chest pain—Doxorubicin—liver cancer	0.000291	0.000793	CcSEcCtD
Oxycodone—Anxiety—Doxorubicin—liver cancer	0.00029	0.00079	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000289	0.000787	CcSEcCtD
Oxycodone—Discomfort—Doxorubicin—liver cancer	0.000288	0.000783	CcSEcCtD
Oxycodone—Anorexia—Epirubicin—liver cancer	0.000288	0.000783	CcSEcCtD
Oxycodone—Dry mouth—Doxorubicin—liver cancer	0.000285	0.000775	CcSEcCtD
Oxycodone—Hypotension—Epirubicin—liver cancer	0.000282	0.000767	CcSEcCtD
Oxycodone—Confusional state—Doxorubicin—liver cancer	0.000281	0.000766	CcSEcCtD
Oxycodone—Anaphylactic shock—Doxorubicin—liver cancer	0.000279	0.00076	CcSEcCtD
Oxycodone—Oedema—Doxorubicin—liver cancer	0.000279	0.00076	CcSEcCtD
Oxycodone—Infection—Doxorubicin—liver cancer	0.000277	0.000755	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000275	0.000748	CcSEcCtD
Oxycodone—Shock—Doxorubicin—liver cancer	0.000275	0.000748	CcSEcCtD
Oxycodone—Nervous system disorder—Doxorubicin—liver cancer	0.000274	0.000745	CcSEcCtD
Oxycodone—Insomnia—Epirubicin—liver cancer	0.000273	0.000743	CcSEcCtD
Oxycodone—Tachycardia—Doxorubicin—liver cancer	0.000272	0.000742	CcSEcCtD
Oxycodone—Skin disorder—Doxorubicin—liver cancer	0.000271	0.000738	CcSEcCtD
Oxycodone—Paraesthesia—Epirubicin—liver cancer	0.000271	0.000738	CcSEcCtD
Oxycodone—Hyperhidrosis—Doxorubicin—liver cancer	0.00027	0.000735	CcSEcCtD
Oxycodone—Dyspnoea—Epirubicin—liver cancer	0.000269	0.000732	CcSEcCtD
Oxycodone—Somnolence—Epirubicin—liver cancer	0.000268	0.00073	CcSEcCtD
Oxycodone—Anorexia—Doxorubicin—liver cancer	0.000266	0.000724	CcSEcCtD
Oxycodone—Dyspepsia—Epirubicin—liver cancer	0.000266	0.000723	CcSEcCtD
Oxycodone—Decreased appetite—Epirubicin—liver cancer	0.000262	0.000714	CcSEcCtD
Oxycodone—Hypotension—Doxorubicin—liver cancer	0.000261	0.00071	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Epirubicin—liver cancer	0.00026	0.000709	CcSEcCtD
Oxycodone—Fatigue—Epirubicin—liver cancer	0.00026	0.000708	CcSEcCtD
Oxycodone—Pain—Epirubicin—liver cancer	0.000258	0.000702	CcSEcCtD
Oxycodone—Constipation—Epirubicin—liver cancer	0.000258	0.000702	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000254	0.000692	CcSEcCtD
Oxycodone—Insomnia—Doxorubicin—liver cancer	0.000252	0.000687	CcSEcCtD
Oxycodone—Paraesthesia—Doxorubicin—liver cancer	0.000251	0.000682	CcSEcCtD
Oxycodone—Dyspnoea—Doxorubicin—liver cancer	0.000249	0.000678	CcSEcCtD
Oxycodone—Feeling abnormal—Epirubicin—liver cancer	0.000249	0.000677	CcSEcCtD
Oxycodone—Somnolence—Doxorubicin—liver cancer	0.000248	0.000676	CcSEcCtD
Oxycodone—Gastrointestinal pain—Epirubicin—liver cancer	0.000247	0.000672	CcSEcCtD
Oxycodone—Dyspepsia—Doxorubicin—liver cancer	0.000246	0.000669	CcSEcCtD
Oxycodone—Decreased appetite—Doxorubicin—liver cancer	0.000243	0.000661	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000241	0.000656	CcSEcCtD
Oxycodone—Fatigue—Doxorubicin—liver cancer	0.000241	0.000655	CcSEcCtD
Oxycodone—Urticaria—Epirubicin—liver cancer	0.00024	0.000652	CcSEcCtD
Oxycodone—Pain—Doxorubicin—liver cancer	0.000239	0.00065	CcSEcCtD
Oxycodone—Constipation—Doxorubicin—liver cancer	0.000239	0.00065	CcSEcCtD
Oxycodone—Body temperature increased—Epirubicin—liver cancer	0.000238	0.000649	CcSEcCtD
Oxycodone—Abdominal pain—Epirubicin—liver cancer	0.000238	0.000649	CcSEcCtD
Oxycodone—Feeling abnormal—Doxorubicin—liver cancer	0.00023	0.000626	CcSEcCtD
Oxycodone—Gastrointestinal pain—Doxorubicin—liver cancer	0.000228	0.000621	CcSEcCtD
Oxycodone—Hypersensitivity—Epirubicin—liver cancer	0.000222	0.000605	CcSEcCtD
Oxycodone—Urticaria—Doxorubicin—liver cancer	0.000222	0.000604	CcSEcCtD
Oxycodone—Abdominal pain—Doxorubicin—liver cancer	0.000221	0.000601	CcSEcCtD
Oxycodone—Body temperature increased—Doxorubicin—liver cancer	0.000221	0.000601	CcSEcCtD
Oxycodone—Asthenia—Epirubicin—liver cancer	0.000216	0.000589	CcSEcCtD
Oxycodone—Pruritus—Epirubicin—liver cancer	0.000213	0.000581	CcSEcCtD
Oxycodone—Diarrhoea—Epirubicin—liver cancer	0.000206	0.000562	CcSEcCtD
Oxycodone—Hypersensitivity—Doxorubicin—liver cancer	0.000206	0.00056	CcSEcCtD
Oxycodone—Asthenia—Doxorubicin—liver cancer	0.0002	0.000545	CcSEcCtD
Oxycodone—Dizziness—Epirubicin—liver cancer	0.000199	0.000543	CcSEcCtD
Oxycodone—Pruritus—Doxorubicin—liver cancer	0.000197	0.000538	CcSEcCtD
Oxycodone—Vomiting—Epirubicin—liver cancer	0.000192	0.000522	CcSEcCtD
Oxycodone—Diarrhoea—Doxorubicin—liver cancer	0.000191	0.00052	CcSEcCtD
Oxycodone—Rash—Epirubicin—liver cancer	0.00019	0.000518	CcSEcCtD
Oxycodone—Dermatitis—Epirubicin—liver cancer	0.00019	0.000517	CcSEcCtD
Oxycodone—Headache—Epirubicin—liver cancer	0.000189	0.000515	CcSEcCtD
Oxycodone—Dizziness—Doxorubicin—liver cancer	0.000185	0.000503	CcSEcCtD
Oxycodone—Nausea—Epirubicin—liver cancer	0.000179	0.000488	CcSEcCtD
Oxycodone—Vomiting—Doxorubicin—liver cancer	0.000177	0.000483	CcSEcCtD
Oxycodone—Rash—Doxorubicin—liver cancer	0.000176	0.000479	CcSEcCtD
Oxycodone—Dermatitis—Doxorubicin—liver cancer	0.000176	0.000479	CcSEcCtD
Oxycodone—Headache—Doxorubicin—liver cancer	0.000175	0.000476	CcSEcCtD
Oxycodone—Nausea—Doxorubicin—liver cancer	0.000166	0.000451	CcSEcCtD
Oxycodone—Naloxone—ALB—liver cancer	0.000143	0.308	CrCbGaD
Oxycodone—OPRM1—GPCR downstream signaling—PIK3CG—liver cancer	3.07e-05	0.000485	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CRABP1—liver cancer	3.06e-05	0.000483	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP2E1—liver cancer	3.01e-05	0.000476	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—EPT1—liver cancer	2.99e-05	0.000472	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CSF2—liver cancer	2.96e-05	0.000468	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—RAF1—liver cancer	2.95e-05	0.000467	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GLUL—liver cancer	2.95e-05	0.000466	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CPT1B—liver cancer	2.95e-05	0.000466	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PRKCE—liver cancer	2.94e-05	0.000464	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—H2AFX—liver cancer	2.92e-05	0.000461	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—IL2—liver cancer	2.92e-05	0.000461	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—F2—liver cancer	2.92e-05	0.000461	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PIK3CD—liver cancer	2.9e-05	0.000458	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PIK3CB—liver cancer	2.88e-05	0.000456	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NR1H4—liver cancer	2.84e-05	0.000449	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TAT—liver cancer	2.84e-05	0.000448	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYCS—liver cancer	2.82e-05	0.000445	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTA3—liver cancer	2.79e-05	0.000441	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CG—liver cancer	2.79e-05	0.000441	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PIK3CB—liver cancer	2.79e-05	0.00044	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IGF2—liver cancer	2.78e-05	0.000439	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GOT1—liver cancer	2.77e-05	0.000437	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GGT1—liver cancer	2.77e-05	0.000437	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PIK3CD—liver cancer	2.7e-05	0.000427	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—HPGDS—liver cancer	2.67e-05	0.000422	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL2—liver cancer	2.65e-05	0.000419	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TERT—liver cancer	2.64e-05	0.000417	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CSF2—liver cancer	2.6e-05	0.00041	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—RAF1—liver cancer	2.59e-05	0.000409	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—H2AFX—liver cancer	2.56e-05	0.000404	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—IL2—liver cancer	2.56e-05	0.000404	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTA4—liver cancer	2.56e-05	0.000404	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PIK3CB—liver cancer	2.53e-05	0.0004	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTA2—liver cancer	2.49e-05	0.000393	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GSTP1—liver cancer	2.48e-05	0.000392	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PRKCE—liver cancer	2.48e-05	0.000392	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CD—liver cancer	2.45e-05	0.000387	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—HMOX1—liver cancer	2.45e-05	0.000387	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—KDR—liver cancer	2.41e-05	0.000381	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTA1—liver cancer	2.4e-05	0.00038	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MAPK14—liver cancer	2.4e-05	0.000379	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PSMA4—liver cancer	2.38e-05	0.000376	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PSMD10—liver cancer	2.38e-05	0.000376	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NAT2—liver cancer	2.38e-05	0.000375	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PIK3CB—liver cancer	2.35e-05	0.000372	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ESR1—liver cancer	2.35e-05	0.000372	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IGF2—liver cancer	2.35e-05	0.000371	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—F2—liver cancer	2.32e-05	0.000367	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL2—liver cancer	2.32e-05	0.000367	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GOT2—liver cancer	2.32e-05	0.000366	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TERT—liver cancer	2.31e-05	0.000366	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GSTM1—liver cancer	2.28e-05	0.000361	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALDOB—liver cancer	2.28e-05	0.00036	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CG—liver cancer	2.22e-05	0.000351	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—APC—liver cancer	2.22e-05	0.000351	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CSF2—liver cancer	2.19e-05	0.000347	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—RAF1—liver cancer	2.19e-05	0.000346	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP2E1—liver cancer	2.18e-05	0.000344	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CRABP1—liver cancer	2.17e-05	0.000343	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP1A1—liver cancer	2.16e-05	0.000342	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—H2AFX—liver cancer	2.16e-05	0.000342	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—IL2—liver cancer	2.16e-05	0.000342	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CB—liver cancer	2.14e-05	0.000338	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KDR—liver cancer	2.12e-05	0.000334	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MAPK14—liver cancer	2.1e-05	0.000332	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—BRAF—liver cancer	2.09e-05	0.00033	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ESR1—liver cancer	2.06e-05	0.000326	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—F2—liver cancer	2.04e-05	0.000322	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYCS—liver cancer	2.04e-05	0.000322	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—MTHFR—liver cancer	2.02e-05	0.000319	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GGT1—liver cancer	2e-05	0.000316	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GOT1—liver cancer	2e-05	0.000316	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PPARA—liver cancer	1.98e-05	0.000313	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL2—liver cancer	1.96e-05	0.00031	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TERT—liver cancer	1.96e-05	0.000309	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CD—liver cancer	1.96e-05	0.000309	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—APC—liver cancer	1.95e-05	0.000308	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CG—liver cancer	1.95e-05	0.000308	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—PIK3CA—liver cancer	1.94e-05	0.000306	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SERPINE1—liver cancer	1.93e-05	0.000305	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GLUL—liver cancer	1.93e-05	0.000304	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CPT1B—liver cancer	1.93e-05	0.000304	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—KRAS—liver cancer	1.91e-05	0.000302	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HPGDS—liver cancer	1.9e-05	0.0003	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NR1H4—liver cancer	1.86e-05	0.000294	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—BRAF—liver cancer	1.83e-05	0.00029	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTA3—liver cancer	1.83e-05	0.000289	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTP1—liver cancer	1.8e-05	0.000284	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KDR—liver cancer	1.79e-05	0.000283	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAPK14—liver cancer	1.78e-05	0.000281	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—HMOX1—liver cancer	1.77e-05	0.00028	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PIK3CA—liver cancer	1.76e-05	0.000278	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—RAF1—liver cancer	1.75e-05	0.000276	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ESR1—liver cancer	1.74e-05	0.000275	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—F2—liver cancer	1.72e-05	0.000272	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CD—liver cancer	1.71e-05	0.000271	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CB—liver cancer	1.7e-05	0.000269	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MTOR—liver cancer	1.7e-05	0.000269	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PIK3CA—liver cancer	1.7e-05	0.000268	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SERPINE1—liver cancer	1.7e-05	0.000268	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CG—liver cancer	1.7e-05	0.000268	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PSMD10—liver cancer	1.69e-05	0.000267	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PSMA4—liver cancer	1.69e-05	0.000267	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—KRAS—liver cancer	1.68e-05	0.000265	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTA4—liver cancer	1.67e-05	0.000264	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTM1—liver cancer	1.65e-05	0.000261	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CG—liver cancer	1.65e-05	0.00026	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APC—liver cancer	1.65e-05	0.00026	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GOT2—liver cancer	1.65e-05	0.00026	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PPARG—liver cancer	1.64e-05	0.000258	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTA2—liver cancer	1.63e-05	0.000257	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—HRAS—liver cancer	1.63e-05	0.000257	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CDKN1B—liver cancer	1.6e-05	0.000253	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—AKT1—liver cancer	1.58e-05	0.00025	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTA1—liver cancer	1.57e-05	0.000248	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CASP3—liver cancer	1.57e-05	0.000248	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL2—liver cancer	1.56e-05	0.000247	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP1A1—liver cancer	1.56e-05	0.000247	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL6—liver cancer	1.56e-05	0.000246	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NAT2—liver cancer	1.55e-05	0.000245	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—BRAF—liver cancer	1.55e-05	0.000245	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP2E1—liver cancer	1.55e-05	0.000245	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PIK3CA—liver cancer	1.54e-05	0.000244	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RAF1—liver cancer	1.53e-05	0.000242	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCND1—liver cancer	1.53e-05	0.000241	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—JUN—liver cancer	1.52e-05	0.000241	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CTNNB1—liver cancer	1.51e-05	0.000239	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CB—liver cancer	1.49e-05	0.000236	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MTOR—liver cancer	1.49e-05	0.000236	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CD—liver cancer	1.49e-05	0.000235	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALDOB—liver cancer	1.49e-05	0.000235	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MMP9—liver cancer	1.48e-05	0.000234	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CDKN1A—liver cancer	1.48e-05	0.000233	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ALB—liver cancer	1.47e-05	0.000232	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—MTHFR—liver cancer	1.46e-05	0.00023	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CD—liver cancer	1.45e-05	0.000229	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYCS—liver cancer	1.45e-05	0.000229	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MAPK8—liver cancer	1.44e-05	0.000228	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—AKT1—liver cancer	1.44e-05	0.000227	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PIK3CA—liver cancer	1.44e-05	0.000227	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SERPINE1—liver cancer	1.43e-05	0.000226	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPARA—liver cancer	1.43e-05	0.000226	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—HRAS—liver cancer	1.43e-05	0.000225	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GGT1—liver cancer	1.42e-05	0.000225	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GOT1—liver cancer	1.42e-05	0.000225	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CRABP1—liver cancer	1.42e-05	0.000224	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—KRAS—liver cancer	1.42e-05	0.000224	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CDKN1B—liver cancer	1.4e-05	0.000222	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—AKT1—liver cancer	1.39e-05	0.000219	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CASP3—liver cancer	1.37e-05	0.000217	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL2—liver cancer	1.37e-05	0.000217	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL6—liver cancer	1.37e-05	0.000216	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCND1—liver cancer	1.34e-05	0.000211	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—JUN—liver cancer	1.33e-05	0.000211	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—VEGFA—liver cancer	1.33e-05	0.00021	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CTNNB1—liver cancer	1.32e-05	0.000209	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—STAT3—liver cancer	1.32e-05	0.000208	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CA—liver cancer	1.3e-05	0.000206	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CB—liver cancer	1.3e-05	0.000205	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MMP9—liver cancer	1.3e-05	0.000205	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CDKN1A—liver cancer	1.29e-05	0.000204	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RAF1—liver cancer	1.29e-05	0.000204	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTP1—liver cancer	1.28e-05	0.000202	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MAPK8—liver cancer	1.26e-05	0.0002	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MTOR—liver cancer	1.26e-05	0.0002	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CB—liver cancer	1.26e-05	0.0002	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—AKT1—liver cancer	1.26e-05	0.000199	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HMOX1—liver cancer	1.26e-05	0.000199	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HPGDS—liver cancer	1.24e-05	0.000196	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CG—liver cancer	1.23e-05	0.000194	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MYC—liver cancer	1.22e-05	0.000193	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TGFB1—liver cancer	1.22e-05	0.000193	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HRAS—liver cancer	1.21e-05	0.00019	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CDKN1B—liver cancer	1.19e-05	0.000187	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPARG—liver cancer	1.18e-05	0.000187	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTM1—liver cancer	1.17e-05	0.000185	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—AKT1—liver cancer	1.17e-05	0.000185	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—VEGFA—liver cancer	1.17e-05	0.000184	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CASP3—liver cancer	1.16e-05	0.000183	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL2—liver cancer	1.16e-05	0.000183	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—STAT3—liver cancer	1.15e-05	0.000182	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL6—liver cancer	1.15e-05	0.000182	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—KRAS—liver cancer	1.13e-05	0.000179	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCND1—liver cancer	1.13e-05	0.000179	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—JUN—liver cancer	1.13e-05	0.000178	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CTNNB1—liver cancer	1.12e-05	0.000177	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP1A1—liver cancer	1.11e-05	0.000176	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PSMD10—liver cancer	1.11e-05	0.000175	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PSMA4—liver cancer	1.11e-05	0.000175	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MMP9—liver cancer	1.1e-05	0.000173	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CDKN1A—liver cancer	1.09e-05	0.000173	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CD—liver cancer	1.08e-05	0.00017	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GOT2—liver cancer	1.08e-05	0.00017	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MYC—liver cancer	1.07e-05	0.00017	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TGFB1—liver cancer	1.07e-05	0.000169	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAPK8—liver cancer	1.07e-05	0.000169	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—AKT1—liver cancer	1.06e-05	0.000168	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ALB—liver cancer	1.06e-05	0.000168	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CA—liver cancer	1.04e-05	0.000164	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—MTHFR—liver cancer	1.04e-05	0.000164	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPARA—liver cancer	1.02e-05	0.000161	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP2E1—liver cancer	1.01e-05	0.00016	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TP53—liver cancer	1e-05	0.000159	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KRAS—liver cancer	9.91e-06	0.000157	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—VEGFA—liver cancer	9.86e-06	0.000156	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—STAT3—liver cancer	9.76e-06	0.000154	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HRAS—liver cancer	9.61e-06	0.000152	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYCS—liver cancer	9.47e-06	0.00015	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CB—liver cancer	9.39e-06	0.000148	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GGT1—liver cancer	9.29e-06	0.000147	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GOT1—liver cancer	9.29e-06	0.000147	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL6—liver cancer	9.2e-06	0.000145	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CA—liver cancer	9.11e-06	0.000144	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MYC—liver cancer	9.07e-06	0.000143	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TGFB1—liver cancer	9.05e-06	0.000143	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TP53—liver cancer	8.81e-06	0.000139	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CG—liver cancer	8.71e-06	0.000138	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AKT1—liver cancer	8.49e-06	0.000134	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HRAS—liver cancer	8.43e-06	0.000133	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPARG—liver cancer	8.41e-06	0.000133	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KRAS—liver cancer	8.38e-06	0.000132	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTP1—liver cancer	8.35e-06	0.000132	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HMOX1—liver cancer	8.23e-06	0.00013	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6—liver cancer	8.07e-06	0.000127	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CA—liver cancer	7.92e-06	0.000125	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CA—liver cancer	7.7e-06	0.000122	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTM1—liver cancer	7.67e-06	0.000121	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CD—liver cancer	7.66e-06	0.000121	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALB—liver cancer	7.56e-06	0.000119	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TP53—liver cancer	7.45e-06	0.000118	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKT1—liver cancer	7.44e-06	0.000118	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP1A1—liver cancer	7.27e-06	0.000115	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HRAS—liver cancer	7.12e-06	0.000113	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6—liver cancer	6.82e-06	0.000108	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MTHFR—liver cancer	6.78e-06	0.000107	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CB—liver cancer	6.68e-06	0.000105	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPARA—liver cancer	6.65e-06	0.000105	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—AKT1—liver cancer	6.47e-06	0.000102	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKT1—liver cancer	6.29e-06	9.94e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CA—liver cancer	5.72e-06	9.04e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CG—liver cancer	5.7e-06	9e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPARG—liver cancer	5.5e-06	8.69e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CD—liver cancer	5.01e-06	7.91e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALB—liver cancer	4.94e-06	7.81e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—AKT1—liver cancer	4.68e-06	7.39e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CB—liver cancer	4.37e-06	6.9e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CA—liver cancer	4.07e-06	6.43e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AKT1—liver cancer	3.32e-06	5.25e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CA—liver cancer	2.66e-06	4.2e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AKT1—liver cancer	2.17e-06	3.43e-05	CbGpPWpGaD
